159 related articles for article (PubMed ID: 27326262)
1. Prognostic Model to Predict Survival Outcome for Curatively Resected Liposarcoma: A Multi-Institutional Experience.
Oh YJ; Yi SY; Kim KH; Cho YJ; Beum SH; Lee YH; Suh JS; Hur H; Kim KS; Kim SH; Choi YD; Shin KH; Jun HJ; Kim SJ; Lee J; Park SH; Noh SH; Rha SY; Kim HS
J Cancer; 2016; 7(9):1174-80. PubMed ID: 27326262
[TBL] [Abstract][Full Text] [Related]
2. Liposarcoma: exploration of clinical prognostic factors for risk based stratification of therapy.
Kim HS; Lee J; Yi SY; Jun HJ; Choi YL; Ahn GH; Seo SW; Lim DH; Ahn YC; Park JO; Kim SJ
BMC Cancer; 2009 Jun; 9():205. PubMed ID: 19558664
[TBL] [Abstract][Full Text] [Related]
3. Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up.
Pearlstone DB; Pisters PW; Bold RJ; Feig BW; Hunt KK; Yasko AW; Patel S; Pollack A; Benjamin RS; Pollock RE
Cancer; 1999 Jan; 85(1):85-92. PubMed ID: 9921978
[TBL] [Abstract][Full Text] [Related]
4. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk.
Dalal KM; Kattan MW; Antonescu CR; Brennan MF; Singer S
Ann Surg; 2006 Sep; 244(3):381-91. PubMed ID: 16926564
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of PIK3CA amplification in curatively resected liposarcoma.
Kim JH; Lee JS; Kim EJ; Park KH; Kim KH; Yi SY; Kim HS; Cho YJ; Shin KH; Ahn JB; Hu H; Kim KS; Choi YD; Kim S; Lee YH; Suh JS; Noh SH; Rha SY; Kim HS
Oncotarget; 2016 Apr; 7(17):24549-58. PubMed ID: 27016421
[TBL] [Abstract][Full Text] [Related]
6. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma.
Singer S; Antonescu CR; Riedel E; Brennan MF
Ann Surg; 2003 Sep; 238(3):358-70; discussion 370-1. PubMed ID: 14501502
[TBL] [Abstract][Full Text] [Related]
7. Myxoid/round cell and pleomorphic liposarcomas: prognostic factors and survival in a series of patients treated at a single institution.
Fiore M; Grosso F; Lo Vullo S; Pennacchioli E; Stacchiotti S; Ferrari A; Collini P; Lozza L; Mariani L; Casali PG; Gronchi A
Cancer; 2007 Jun; 109(12):2522-31. PubMed ID: 17510918
[TBL] [Abstract][Full Text] [Related]
8. Liposarcoma of the extremities: MR imaging features and their correlation with pathologic data.
El Ouni F; Jemni H; Trabelsi A; Ben Maitig M; Arifa N; Ben Rhouma K; Ben Ayech M; Tlili K
Orthop Traumatol Surg Res; 2010 Dec; 96(8):876-83. PubMed ID: 20934400
[TBL] [Abstract][Full Text] [Related]
9. Correlation of histological grade of dedifferentiation with clinical outcome in 55 patients with dedifferentiated liposarcomas.
Dantey K; Schoedel K; Yergiyev O; Bartlett D; Rao UNM
Hum Pathol; 2017 Aug; 66():86-92. PubMed ID: 28300575
[TBL] [Abstract][Full Text] [Related]
10. Liposarcoma: outcome and prognostic factors following conservation surgery and radiation therapy.
Zagars GK; Goswitz MS; Pollack A
Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):311-9. PubMed ID: 8892453
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of histologic subtypes in primary extremity liposarcoma.
Chang HR; Hajdu SI; Collin C; Brennan MF
Cancer; 1989 Oct; 64(7):1514-20. PubMed ID: 2776110
[TBL] [Abstract][Full Text] [Related]
12. Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age.
Alaggio R; Coffin CM; Weiss SW; Bridge JA; Issakov J; Oliveira AM; Folpe AL
Am J Surg Pathol; 2009 May; 33(5):645-58. PubMed ID: 19194281
[TBL] [Abstract][Full Text] [Related]
13. Primary intrathoracic liposarcoma: a clinicopathologic study and prognostic analysis of 23 cases.
Chen M; Yang J; Zhu L; Zhou C; Zhao H
J Cardiothorac Surg; 2014 Jul; 9():119. PubMed ID: 24993036
[TBL] [Abstract][Full Text] [Related]
14. Liposarcomas of the mediastinum and thorax: a clinicopathologic and molecular cytogenetic study of 24 cases, emphasizing unusual and diverse histologic features.
Boland JM; Colby TV; Folpe AL
Am J Surg Pathol; 2012 Sep; 36(9):1395-403. PubMed ID: 22895273
[TBL] [Abstract][Full Text] [Related]
15. Differences in recurrence and survival of extremity liposarcoma subtypes.
Vos M; Koseła-Paterczyk H; Rutkowski P; van Leenders GJLH; Normantowicz M; Lecyk A; Sleijfer S; Verhoef C; Grünhagen DJ
Eur J Surg Oncol; 2018 Sep; 44(9):1391-1397. PubMed ID: 29673808
[TBL] [Abstract][Full Text] [Related]
16. Primary anatomical site as a prognostic factor for pleomorphic liposarcoma.
Lee HG; Aurit S; Silberstein P; Gootee J
J Cancer Res Clin Oncol; 2020 Jun; 146(6):1501-1508. PubMed ID: 32248301
[TBL] [Abstract][Full Text] [Related]
17. Dedifferentiated liposarcoma. Clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas.
McCormick D; Mentzel T; Beham A; Fletcher CD
Am J Surg Pathol; 1994 Dec; 18(12):1213-23. PubMed ID: 7977944
[TBL] [Abstract][Full Text] [Related]
18. Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery.
Keung EZ; Hornick JL; Bertagnolli MM; Baldini EH; Raut CP
J Am Coll Surg; 2014 Feb; 218(2):206-17. PubMed ID: 24315890
[TBL] [Abstract][Full Text] [Related]
19. Dedifferentiated liposarcoma in the extremity and trunk wall: A multi-institutional study of 132 cases by the Japanese Musculoskeletal Oncology Group (JMOG).
Morii T; Anazawa U; Sato C; Iwata S; Nakagawa M; Endo M; Nakamura T; Ikuta K; Nishida Y; Nakayama R; Udaka T; Kawamoto T; Kito M; Sato K; Imanishi J; Akiyama T; Kobayashi H; Nagano A; Outani H; Toki S; Nishisho T; Sasa K; Suehara Y; Kawano H; Ueda T; Morioka H
Eur J Surg Oncol; 2023 Feb; 49(2):353-361. PubMed ID: 36088237
[TBL] [Abstract][Full Text] [Related]
20. The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma.
Eilber FC; Eilber FR; Eckardt J; Rosen G; Riedel E; Maki RG; Brennan MF; Singer S
Ann Surg; 2004 Oct; 240(4):686-95; discussion 695-7. PubMed ID: 15383796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
